Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia
We aimed to evaluate the key diagnostic features of Guillain-Barre syndrome (GBS) in Malaysian patients and validate the Brighton criteria. This was a retrospective study of patients presenting with GBS and Miller Fisher syndrome (MFS) between 2010 and 2019. The sensitivity of the Brighton criteria...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Published: |
Wiley
2020
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/36601/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.36601 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.366012024-11-28T04:03:16Z http://eprints.um.edu.my/36601/ Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia Tan, Cheng-Yin Razali, Siti Nur Omaira Goh, Khean-Jin Shahrizaila, Nortina RC Internal medicine RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry We aimed to evaluate the key diagnostic features of Guillain-Barre syndrome (GBS) in Malaysian patients and validate the Brighton criteria. This was a retrospective study of patients presenting with GBS and Miller Fisher syndrome (MFS) between 2010 and 2019. The sensitivity of the Brighton criteria was evaluated. A total of 128 patients (95 GBS, 33 MFS) were included. In the GBS cohort, 92 (97%) patients presented with symmetrical limb weakness. Reflexes were depressed or absent in 90 (95%) patients. Almost all patients (94, 99%) followed a monophasic disease course, with 5 (5%) patients experiencing treatment-related fluctuations. Cerebrospinal fluid (CSF) albuminocytological dissociation was seen in 62/84 (73%) patients. Nerve conduction study (NCS) revealed neuropathy in 90/94 (96%) patients. In GBS patients with complete dataset (84), 56 (67%) patients reached level 1 of the Brighton criteria, 21 (25%) reached level 2, 3 (4%) reached level 3, and 4 (5%) reached level 4. In MFS, the clinical triad was present in 25 (76%) patients. All patients had a monophasic course. CSF albuminocytological dissociation was present in 10/25 (40%) patients. NCS was normal or showed sensory neuropathy in 25/33 (76%) patients. In MFS patients with complete dataset (25), 5 (20%) patients reached level 1 of the Brighton criteria, 14 (56%) reached level 2, 2 (8%) reached level 3, and 4 (16%) reached level 4. Inclusion of antiganglioside antibodies improved the sensitivity of the Brighton criteria in both cohorts. In the Malaysian cohort, the Brighton criteria showed a moderate to high sensitivity in reaching the highest diagnostic certainty of GBS, but the sensitivity was lower in MFS. Wiley 2020-09 Article PeerReviewed Tan, Cheng-Yin and Razali, Siti Nur Omaira and Goh, Khean-Jin and Shahrizaila, Nortina (2020) Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia. Journal of the Peripheral Nervous System, 25 (3). pp. 256-264. ISSN 1085-9489, DOI https://doi.org/10.1111/jns.12398 <https://doi.org/10.1111/jns.12398>. 10.1111/jns.12398 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
RC Internal medicine RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
spellingShingle |
RC Internal medicine RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry Tan, Cheng-Yin Razali, Siti Nur Omaira Goh, Khean-Jin Shahrizaila, Nortina Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
description |
We aimed to evaluate the key diagnostic features of Guillain-Barre syndrome (GBS) in Malaysian patients and validate the Brighton criteria. This was a retrospective study of patients presenting with GBS and Miller Fisher syndrome (MFS) between 2010 and 2019. The sensitivity of the Brighton criteria was evaluated. A total of 128 patients (95 GBS, 33 MFS) were included. In the GBS cohort, 92 (97%) patients presented with symmetrical limb weakness. Reflexes were depressed or absent in 90 (95%) patients. Almost all patients (94, 99%) followed a monophasic disease course, with 5 (5%) patients experiencing treatment-related fluctuations. Cerebrospinal fluid (CSF) albuminocytological dissociation was seen in 62/84 (73%) patients. Nerve conduction study (NCS) revealed neuropathy in 90/94 (96%) patients. In GBS patients with complete dataset (84), 56 (67%) patients reached level 1 of the Brighton criteria, 21 (25%) reached level 2, 3 (4%) reached level 3, and 4 (5%) reached level 4. In MFS, the clinical triad was present in 25 (76%) patients. All patients had a monophasic course. CSF albuminocytological dissociation was present in 10/25 (40%) patients. NCS was normal or showed sensory neuropathy in 25/33 (76%) patients. In MFS patients with complete dataset (25), 5 (20%) patients reached level 1 of the Brighton criteria, 14 (56%) reached level 2, 2 (8%) reached level 3, and 4 (16%) reached level 4. Inclusion of antiganglioside antibodies improved the sensitivity of the Brighton criteria in both cohorts. In the Malaysian cohort, the Brighton criteria showed a moderate to high sensitivity in reaching the highest diagnostic certainty of GBS, but the sensitivity was lower in MFS. |
format |
Article |
author |
Tan, Cheng-Yin Razali, Siti Nur Omaira Goh, Khean-Jin Shahrizaila, Nortina |
author_facet |
Tan, Cheng-Yin Razali, Siti Nur Omaira Goh, Khean-Jin Shahrizaila, Nortina |
author_sort |
Tan, Cheng-Yin |
title |
Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
title_short |
Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
title_full |
Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
title_fullStr |
Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
title_full_unstemmed |
Diagnosis of Guillain-Barresyndrome and validation of the brighton criteria in Malaysia |
title_sort |
diagnosis of guillain-barresyndrome and validation of the brighton criteria in malaysia |
publisher |
Wiley |
publishDate |
2020 |
url |
http://eprints.um.edu.my/36601/ |
_version_ |
1817841979519664128 |
score |
13.222552 |